Search results
- 39.47Add to watchlist-0.37 (-0.92%)As of Thu. Jul 18, 2024 2:08 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open39.74High39.83Low39.47
- Mkt Cap80.49BP/E (TTM)14.00Div & Yield1.49 & 3.74%
- Prev. Close39.8452 Wk. Low33.6752 Wk. High45.92
What analysts are sayingTop storiesGSK plc (GSK): Is It the Best FTSE Dividend Stock to Buy According to Hedge Funds?Yahoo Finance · 1 week agoIs GSK an Attractive Drug Stock to Add to Your Portfolio Now?Yahoo Finance · 1 week agoShould We Be Delighted With GSK plc's (LON:GSK) ROE Of 36%?Yahoo Finance · 2 weeks agoRelated stocks
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
GSK Science in the Summer™ Through our STEM investments, we aim to equitably increase children’s confidence in doing science and pursuing STEM careers. That's why we offer GSK Science in the Summer™, a free, inquiry-based science education program that helps students grow to love science.
Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
From quarterly updates to key announcements, here you can access GSK investor-related information.
Meet our people. We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore GSK in the US.
Globally, our portfolio spans vaccines, specialty and general medicines, with R&D focused on science of the immune system, human genetics and advanced technologies. GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions.
2 days ago · GSK Plc’s chief executive officer said the UK drugmaker is ready to partner with the new Labour government on research and development as it seeks to boost Britain’s standing as an innovation hub.